Event-Driven Stocks

PRECISION BIOSCIENCES INC

DTIL

Other · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 1 good● 5 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$34.3M$68.7M$48.7M$25.1M$115.5M$24.3M
Operating income−$52.1M−$26.2M−$43.7M−$62.3M−$39.4M−$109.8M
Net income−$45.7M$7.2M−$61.3M−$111.6M−$30.6M−$109.0M
Total assets$154.4M$136.4M$159.8M$238.2M$211.5M$150.2M
Total liabilities$62.2M$80.0M$140.9M$177.7M$120.3M$105.7M
Equity$92.2M$56.4M$18.9M$60.4M$91.2M$44.4M
EPS (diluted)$-3.56$1.04$-15.96$-38.10$-0.52—
Shares out.10.5M6.9M111.3M61.0M57.0M51.4M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−152.2%
Net margin
−133.4%
Return on equity
−49.6%
Return on assets
−29.6%
Return on capital (ROCE)
−35.8%
Liabilities / assets
40.3%
Debt / equity
0.67×
Book value / share
$8.80
Revenue growth (YoY)
−50.1%
Net income growth (YoY)
−738.0%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-7.20distress
Accruals / assets
13.0%high accruals
Piotroski F-Score
2/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
22
/ 100
Profitability 0Growth 0Catalyst 33Earnings quality 0Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

● 1 severe● 5 warning● 1 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • Negative operating cash flow
  • High accruals — earnings-quality risk
  • Conservative leverage (liabilities < 50% of assets)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Insider transactions

SEC Form 4 · most recent
12 acquisitions0 disposalsnet +248,469 shares · last 12
InsiderDateTypeSharesPrice
Buehler KevinDirectorMay 20, 2026Option exercise21,000—
Frankel StanleyDirectorMay 20, 2026Option exercise21,000—
Brown MelindaDirectorMay 20, 2026Option exercise21,000—
Pire Shari LisaDirectorMay 20, 2026Option exercise21,000—
Germano Geno JDirectorMay 20, 2026Option exercise21,000—
Amoroso MichaelOfficer — President and CEOFeb 17, 2026Option exercise67,797$0.00
Kelly John AlexanderOfficer — Chief Financial OfficerFeb 17, 2026Option exercise27,584$0.00
Scimeca DarioOfficer — General Counsel and SecretaryFeb 17, 2026Option exercise16,667$0.00
Smith J. JeffersonOfficer — Chief Research OfficerFeb 17, 2026Option exercise16,667$0.00
Amoroso MichaelOfficer — President and CEOJan 20, 2026Option exercise8,888—
Scimeca DarioOfficer — General Counsel and SecretaryJan 20, 2026Option exercise1,978$0.00
Kelly John AlexanderOfficer — Chief Financial OfficerJan 20, 2026Option exercise3,888—

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20261.5M6.5+7.0%
Apr 30, 20261.4M8.1+13.4%
Apr 15, 20261.2M4.6+6.6%
Mar 31, 20261.2M2.7-16.2%
Mar 13, 20261.4M5.0+0.9%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.